On February 3, 2026, at the invitation of the Pharmaceutical Research and Manufacturers of America (PhRMA), Chinese Ambassador to the United States, Xie Feng, engaged in a meeting with Stephen J. Ubl, PhRMA's President and CEO. During this meeting, the two parties delved into a comprehensive discussion regarding the policy landscapes within the biopharmaceutical sectors of both China and the United States, along with exploring avenues for pharmaceutical collaboration between the two nations.
